Press Resease

Respiratory Disorders Treatment Market - Global Industry Analysis

Respiratory Disorders Treatment Market - By Disease(Asthma, Chronic Obstructive Pulmonary Disease [COPD], Lung Cancer, Respiratory Tract Infection, Allergic Rhinitis, Cystic Fibrosis [CF]), By Drug Class (Bronchodilators, Combination Drugs, Immunotherapy, Corticosteroids, Antibiotics, CFTR, Target Therapy, and Immunotherapy), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Route of Administration (Oral, Nasal, and Injectable), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 19-Aug-2021 Category: Pharmaceutical Report Format : PDF Report Code: ZMR-6607 Status : Published

The global Respiratory Disorders Treatment market accrued earnings worth approximately 98.9 (USD Billion) in 2020 and is predicted to gain revenue of about 112.5(USD Billion) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028.

Description

The global Respiratory Disorders Treatment market accrued earnings worth approximately 98.9 (USD Billion) in 2020 and is predicted to gain revenue of about 112.5(USD Billion) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028. The report offers assessment and analysis of the Respiratory Disorders Treatment market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Report Scope :

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Respiratory Disorders Treatment Market: Outlook

Respiratory disorders are life-threatening health problems and classified under four categories such as acute disorders, chronic ailments, occupational lung diseases, and parenchymal lung ailments. Acute disorders include influenza and pneumonia, chronic ailments are asthma and chronic obstructive pulmonary disease, and occupational lung diseases include asbestosis, byssinosis, & coal worker’s pneumoconiosis. Additionally, parenchymal lung ailments encompass immune related lung disorders. Furthermore, various kinds of therapies are utilized for treating these respiratory disorders that include mind-body therapies, integrative modalities, pharmacotreatment, supplements, nutrition, and self-care strategies.

Additionally, respiratory disorders are both non-communicable & communicable that can prove to be fatal for patients and result in mortality, economic burden on patients, and disability adjusted life years. Asthma is one of the best examples of non-communicable respiratory ailment and tuberculosis is one of the most common communicable respiratory diseases. Today, most of chronic obstructive pulmonary disorders are treated through inhaled corticosteroids. Apart from this, chronic respiratory disorders can be treated with bronchodilator and antibiotics. Moreover, COVID-19 is being treated through Remdesivir inoculation, ingestion of Paracetamol, and plasma therapies.

Respiratory Disorders Treatment Market: Growth Drivers

Massive use of leukotriene blocking agents in treating asthma due to its proven efficacy and launching of new drugs for treating respiratory disorders will benefit growth of respiratory disorders treatment market. Apparently, rise in cases of lung transplantation in countries such as the U.S. and the UK is likely to aid respiratory disorders treatment industry expansion. Lung tissue repair & regeneration helps in rebuilding lungs after suffering damages from respiratory disorders. Large-scale use of mepolizumab and omalizumab for treating severe asthma to drive business landscape. This will further add towards growth of respiratory disorders treatment market over forthcoming years. Breakthroughs in drug development for treating respiratory disorders will embellish growth of respiratory disorders treatment industry during forecast period.

Furthermore, large-scale use of translational lung medicine for treating respiratory ailments will proliferate expansion of respiratory disorders treatment market. Rise in research on lung microbiome will help in new drug discovery for treating chronic respiratory illness, thereby providing lucrative growth avenues for respiratory disorders treatment industry. Increase in respiratory illness due to rise in pollution due to emissions from vehicles on roads along with rise in combined drug therapy for treating respiratory disorders will multiply development of respiratory disorders treatment industry.

Regional Landscape

North America To Contribute Substantially Towards Market Profitability By 2028

The regional market growth during forecast timeline can be attributed to cost-efficiency of interventions for chronic obstructive pulmonary disorders & asthma in countries such as the U.S. and Canada. In addition to this, chronic respiratory disorders are a huge burden for healthcare systems in the U.S. and this will enhance market penetration in the sub-continent. Additionally, early risk diagnosis, preventive measures, participation of individuals & communities, and preemptive approaches will boost business growth trends. Development of advanced tools including RNA interference, cell-based approaches, tissue engineering, database sharing, high-throughput proteomic technologies, synthetic biology, imaging, microfluidics, and nanotechnology will steer regional market size.

Competitive Landscape

Key participants profiled in study and impacting industry growth are Mylan N.V., GlaxoSmithKline plc, Novartis AG, Cipla, Roche Diagnostics, AstraZeneca plc, Sanofi, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries, CHIESI Farmaceutici S.p.A, and Vertex Pharmaceuticals Incorporated.  

The global Respiratory Disorders Treatment Market is segmented as follows:

By Disease

  • Asthma
  • Chronic Obstructive Pulmonary Disease [COPD]
  • Lung Cancer
  • Respiratory Tract Infection
  • Allergic Rhinitis
  • Cystic Fibrosis [CF]

By Drug Class

  • Bronchodilators 
  • Corticosteroids
  • Combination Drugs
  • Antibiotics
  • Target Therapy
  • Immunotherapy
  • CFTR

By Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

By Route of Administration

  • Oral
  • Nasal
  • Injectable

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
    • 2.2. Respiratory Disorders Treatment Market: Snapshot
  • Chapter 3. Global Respiratory Disorders Treatment Market– Industry Analysis
    • 3.1. Respiratory Disorders Treatment Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Humungous application of leukotriene blocking agents in treating asthma due to its proved efficiency and introduction of novel medicines for treating respiratory ailments will aid growth of respiratory disorders treatment market.
      • 3.2.2. Surge in cases of lung transplantation in countries such as the U.S. and the UK is likely to augment scope of respiratory disorders treatment market during 2021-2028.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Disease
      • 3.4.2. Market attractiveness analysis By Drug Class
      • 3.4.3. Market attractiveness analysis By Route of Administration
      • 3.4.4. Market attractiveness analysis By Distribution Channel
  • Chapter 4. Global Respiratory Disorders Treatment Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Respiratory Disorders Treatment Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Respiratory Disorders Treatment Market– Disease Analysis
    • 5.1. Global Respiratory Disorders Treatment Market overview: By Disease
      • 5.1.1. Global Respiratory Disorders Treatment Market share, By Disease, 2020 and 2028
    • 5.2. Asthma
      • 5.2.1. Global Respiratory Disorders Treatment Market by Asthma, 2018–2028(USD Billion)
    • 5.3. Chronic Obstructive Pulmonary Disease [COPD]
      • 5.3.1. Global Respiratory Disorders Treatment Market by Chronic Obstructive Pulmonary Disease [COPD], 2018–2028(USD Billion)
    • 5.4. Lung Cancer
      • 5.4.1. Global Respiratory Disorders Treatment Market by Lung Cancer, 2018–2028(USD Billion)
    • 5.5. Respiratory Tract Infection
      • 5.5.1. Global Respiratory Disorders Treatment Market by Respiratory Tract Infection, 2018–2028(USD Billion)
    • 5.6. Cystic Fibrosis [CF]
      • 5.6.1. Global Respiratory Disorders Treatment Market by Cystic Fibrosis [CF], 2018–2028(USD Billion)
    • 5.7. Allergic Rhinitis
      • 5.7.1. Global Respiratory Disorders Treatment Market by Allergic Rhinitis, 2018–2028(USD Billion)
  • Chapter 6. Global Respiratory Disorders Treatment Market– Drug Class Analysis
    • 6.1. Global Respiratory Disorders Treatment Market overview: By Drug Class
      • 6.1.1. Global Respiratory Disorders Treatment Market share, By Drug Class, 2020 and 2028
    • 6.2. Bronchodilators
      • 6.2.1. Global Respiratory Disorders Treatment Market by Bronchodilators , 2018–2028(USD Billion)
    • 6.3. Corticosteroids
      • 6.3.1. Global Respiratory Disorders Treatment Market by Corticosteroids, 2018–2028(USD Billion)
    • 6.4. Combination Drugs
      • 6.4.1. Global Respiratory Disorders Treatment Market by Combination Drugs, 2018–2028(USD Billion)
    • 6.5. Antibiotics
      • 6.5.1. Global Respiratory Disorders Treatment Market by Antibiotics, 2018–2028(USD Billion)
    • 6.6. Target Therapy
      • 6.6.1. Global Respiratory Disorders Treatment Market by Target Therapy, 2018–2028(USD Billion)
    • 6.7. Immunotherapy
      • 6.7.1. Global Respiratory Disorders Treatment Market by Immunotherapy, 2018–2028(USD Billion)
    • 6.8. CFTR
      • 6.8.1. Global Respiratory Disorders Treatment Market by CFTR, 2018–2028(USD Billion)
  • Chapter 7. Global Respiratory Disorders Treatment Market– Route of Administration Analysis
    • 7.1. Global Respiratory Disorders Treatment Market overview: By Route of Administration
      • 7.1.1. Global Respiratory Disorders Treatment Market share, By Route of Administration, 2020 and 2028
    • 7.2. Oral
      • 7.2.1. Global Respiratory Disorders Treatment Market by Oral , 2018–2028(USD Billion)
    • 7.3. Nasal
      • 7.3.1. Global Respiratory Disorders Treatment Market by Nasal, 2018–2028(USD Billion)
    • 7.4. Injectable
      • 7.4.1. Global Respiratory Disorders Treatment Market by Injectable, 2018–2028(USD Billion)
  • Chapter 8. Global Respiratory Disorders Treatment Market overview: By Distribution Channel
    • 8.1.1. Global Respiratory Disorders Treatment Market share, By Distribution Channel, 2020 and 2028
    • 8.2. Hospital Pharmacies
      • 8.2.1. Global Respiratory Disorders Treatment Market by Hospital Pharmacies , 2018–2028(USD Billion)
    • 8.3. Online Pharmacies
      • 8.3.1. Global Respiratory Disorders Treatment Market by Online Pharmacies, 2018–2028(USD Billion)
    • 8.4. Retail Pharmacies
      • 8.4.1. Global Respiratory Disorders Treatment Market by Retail Pharmacies, 2018–2028(USD Billion)
  • Chapter 9. Company Profiles
    • 9.1. Mylan N.V.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. GlaxoSmithKline plc
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Novartis AG
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Development
    • 9.4. Cipla
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Development
    • 9.5. Roche Diagnostics
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. AstraZeneca plc
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. Sanofi
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Merck & Co., Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. Boehringer Ingelheim International GmbH
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. Teva Pharmaceutical Industries
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development
    • 9.11. CHIESI Farmaceutici S.p.A
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product Portfolio
      • 9.11.4. Business Strategy
      • 9.11.5. Recent Development
    • 9.12. Vertex Pharmaceuticals Incorporated
      • 9.12.1. Overview
      • 9.12.2. Financials
      • 9.12.3. Product Portfolio
      • 9.12.4. Business Strategy
      • 9.12.5. Recent Development

List of Figures


1. Market research Type
2. Market research methodology
3. Global Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Respiratory Disorders Treatment Marketattractiveness, By Disease
6. Global Respiratory Disorders Treatment Marketattractiveness, By Route of Administration
7. Global Respiratory Disorders Treatment Marketattractiveness, By Drug Class
8. Global Respiratory Disorders Treatment Marketattractiveness, By Distribution Channel
9. Global Respiratory Disorders Treatment Marketshare by Disease ,2020 and 2028 (USD Billion)
10. Global Respiratory Disorders Treatment Marketby Asthma, 2018–2028(USD Billion)
11. Global Respiratory Disorders Treatment Marketby Chronic Obstructive Pulmonary Disease [COPD], 2018–2028(USD Billion)
12. Global Respiratory Disorders Treatment Marketby Lung Cancer, 2018–2028(USD Billion)
13. Global Respiratory Disorders Treatment Marketby Respiratory Tract Infection, 2018–2028(USD Billion)
14. Global Respiratory Disorders Treatment Marketby Allergic Rhinitis, 2018–2028(USD Billion)
15. Global Respiratory Disorders Treatment Marketby Cystic Fibrosis [CF],2018–2028(USD Billion)
16. Global Respiratory Disorders Treatment Marketshare by Drug Class ,2020 and 2028 (USD Billion)
17. Global Respiratory Disorders Treatment Marketby Bronchodilators  , 2018–2028(USD Billion)
18. Global Respiratory Disorders Treatment Marketby Corticosteroids, 2018–2028(USD Billion)
19. Global Respiratory Disorders Treatment Marketby Combination Drugs, 2018–2028(USD Billion)
20. Global Respiratory Disorders Treatment Marketby Antibiotics, 2018–2028(USD Billion)
21. Global Respiratory Disorders Treatment Marketby Target Therapy, 2018–2028(USD Billion)
22. Global Respiratory Disorders Treatment Marketby CFTR, 2018–2028(USD Billion)
23. Global Respiratory Disorders Treatment Marketby Immunotherapy, 2018–2028(USD Billion)
24. Global Respiratory Disorders Treatment Marketshare by Route of Administration ,2020 and 2028 (USD Billion)
25. Global Respiratory Disorders Treatment Marketby Oral,  2018–2028(USD Billion)
26. Global Respiratory Disorders Treatment Marketby Nasal, 2018–2028(USD Billion)
27. Global Respiratory Disorders Treatment Marketby Injectable, 2018–2028(USD Billion)
28. Global Respiratory Disorders Treatment Marketshare by Distribution Channel ,2020 and 2028 (USD Billion)
29. Global Respiratory Disorders Treatment Marketby Hospital Pharmacies,  2018–2028(USD Billion)
30. Global Respiratory Disorders Treatment Marketby Retail Pharmacies, 2018–2028(USD Billion)
31. Global Respiratory Disorders Treatment Marketby Online Pharmacies, 2018–2028(USD Billion)
32. Global Respiratory Disorders Treatment Marketshare, by Region, 2020 and 2028
33. North America Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
34. Europe Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
35. Asia Pacific Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
36. Latin America Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
37. The Middle East and Africa Respiratory Disorders Treatment Market, 2018–2028(USD Billion)
 


List of Tables

1. Global Respiratory Disorders Treatment Market: snapshot
2. Drivers of the Respiratory Disorders Treatment Market: impact analysis
3. North America Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
4. North America Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
5. North America Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
6. North America Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
7. The U.S. Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
8. The U.S. Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
9. The U.S. Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
10. The U.S. Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
11. Rest of North America Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
12. Rest of North America Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
13. Rest of North America Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
14. Rest of North America Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
15. Europe Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
16. Europe Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
17. Europe Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
18. Europe Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
19. UK Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
20. UK Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
21. UK Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
22. UK Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
23. France Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
24. France Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
25. France Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
26. France Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
27. Germany Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
28. Germany Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
29. Germany Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
30. Germany Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
31. Rest of Europe Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
32. Rest of Europe Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
33. Rest of Europe Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
34. Rest of Europe Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
35. Asia Pacific Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
36. Asia Pacific Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
37. Asia Pacific Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
38. Asia Pacific Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
39. China Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
40. China Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
41. China Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
42. China Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
43. Japan Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
44. Japan Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
45. Japan Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
46. Japan Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
47. India Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
48. India Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
49. India Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
50. India Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
51. Rest of Asia Pacific Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
52. Rest of Asia Pacific Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
53. Rest of Asia Pacific Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
54. Rest of Asia Pacific Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
55. Latin America Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
56. Latin America Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
57. Latin America Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
58. Latin America Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
59. Brazil Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
60. Brazil Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
61. Brazil Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
62. Brazil Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
63. Rest of Latin America Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
64. Rest of Latin  America Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
65. Rest of Latin America Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
66. Rest of Latin  America Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
67. The Middle East and Africa Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
68. The Middle East and Africa Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
69. The Middle East and Africa Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
70. The Middle East and Africa Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
71. Saudi Arabia Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
72. Saudi Arabia Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
73. Saudi Arabia Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
74. Saudi Arabia Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
75. South Africa Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
76. South Africa Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
77. South Africa Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
78. South Africa Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
79. Rest of the Middle East & Africa Respiratory Disorders Treatment Market revenue, By Disease  ,2018–2028(USD Billion)
80. Rest of the Middle East & Africa Respiratory Disorders Treatment Market revenue, By Drug Class  ,2018–2028(USD Billion)
81. Rest of the Middle East & Africa Respiratory Disorders Treatment Market revenue, By Route of Administration  ,2018–2028(USD Billion)
82. Rest of the Middle East & Africa Respiratory Disorders Treatment Market revenue, By Distribution Channel ,2018–2028(USD Billion)
 
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Massive use of leukotriene blocking agents in treating asthma due to its proven efficacy and launching of new drugs for treating respiratory disorders will benefit growth of respiratory disorders treatment market. Apparently, rise in cases of lung transplantation in countries such as the U.S. and the UK is likely to aid respiratory disorders treatment industry expansion. Lung tissue repair & regeneration helps in rebuilding lungs after suffering damages from respiratory disorders. Breakthroughs in drug development for treating respiratory disorders will embellish growth of respiratory disorders treatment industry during forecast period.

Furthermore, large-scale use of translational lung medicine for treating respiratory ailments will proliferate expansion of respiratory disorders treatment market. Surge in respiratory illness due to rise in pollution due to emissions from vehicles on roads along with rise in combined drug therapy for treating respiratory disorders will multiply development of respiratory disorders treatment industry.

According to Zion market research report, the global Respiratory Disorders Treatment market accrued earnings worth approximately 98.9 (USD Billion) in 2020 and is predicted to gain revenue of about 112.5(USD Billion) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028.

North America will account notably towards the global market value over the estimated timeline. The regional market surge is subject to cost-efficiency of interventions for chronic obstructive pulmonary disorders & asthma in countries such as the U.S. and Canada. In addition to this, chronic respiratory disorders are a huge burden for healthcare systems in the U.S. and this will enhance market penetration in the sub-continent. Additionally, early risk diagnosis, preventive measures, participation of individuals & communities, and preemptive approaches will boost business growth trends. Development of advanced tools including RNA interference, cell-based approaches, tissue engineering, database sharing, high-throughput proteomic technologies, synthetic biology, imaging, microfluidics, and nanotechnology will steer regional market size.    

The key market participants include Mylan N.V., GlaxoSmithKline plc, Novartis AG, Cipla, Roche Diagnostics, AstraZeneca plc, Sanofi, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries, CHIESI Farmaceutici S.p.A, and Vertex Pharmaceuticals Incorporated.

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social